SAHPRA - South African Health Products Regulatory Authority
Unclaimed Business
|1|2 Reviews (last 12 months)|This business does not respond to reviews
SAHPRA - South African Health Products Regulatory Authority
Unclaimed Business
|1
2 Reviews (last 12 months)
Does not respond to reviews
Performance(last 12 months):
NPS Score
-100Unlikely
NPS Score
-100
Recommended: Unlikely
Review Distribution
1|2 Reviews
Sep '25 - Aug '26
Recent reviews (2)
Used this business recently? Share your experience to help others decide.
Used this business recently? Share your experience to help others decide.
Share Your ExperiencemC
michelle C
1 reviews | Active since Apr 2014
6 May 2026, 17:22
African People excluded from international medications
As a South African patient living with severe refractory lupus and antiphospholipid syndrome, I am deeply distressed by the lack of access to modern biologic therapies available elsewhere in the world. While patients in the USA, UK and Europe increasingly have access to advanced lupus treatments such as Saphnelo (Anifrolumab), many African patients remain trapped in years of chronic corticosteroid treatment because these biologics are either unavailable, unaffordable, or extremely difficult to access through regulatory pathways. The result for many patients is devastating: severe steroid damage skin atrophy chronic inflammation disability preventable complications declining quality of life African lupus patients deserve the same opportunity to access modern medicine as patients in developed countries. No patient should suffer irreversible damage simply because of where they live. I urge pharmaceutical companies, regulators, healthcare systems and global lupus organizations to acknowledge the growing treatment inequality facing autoimmune patients across Africa and to work toward meaningful access pathways for severe refractory disease. This is not only a South African issue — it is a global health equity issue.
Helpful (0)
|Replies (0)mC
michelle C
1 reviews | Active since Apr 2014
6 May 2026, 17:22
African People excluded from international medications
As a South African patient living with severe refractory lupus and antiphospholipid syndrome, I am deeply distressed by the lack of access to modern biologic therapies available elsewhere in the world. While patients in the USA, UK and Europe increasingly have access to advanced lupus treatments such as Saphnelo (Anifrolumab), many African patients remain trapped in years of chronic corticosteroid treatment because these biologics are either unavailable, unaffordable, or extremely difficult to access through regulatory pathways. The result for many patients is devastating: severe steroid damage skin atrophy chronic inflammation disability preventable complications declining quality of life African lupus patients deserve the same opportunity to access modern medicine as patients in developed countries. No patient should suffer irreversible damage simply because of where they live. I urge pharmaceutical companies, regulators, healthcare systems and global lupus organizations to acknowledge the growing treatment inequality facing autoimmune patients across Africa and to work toward meaningful access pathways for severe refractory disease. This is not only a South African issue — it is a global health equity issue.
0
Replies (0)JDS
J.Luis Da Silva
1 reviews | Active since Jun 2023
25 Nov 2025, 16:24
Subject: Complaint Under the Consumer Protection Act — Misrepresentation & Defective Goods: GLP-1 (Six-in-One)
I wish to lodge a formal complaint with SAHPRA regarding a suspected falsified or substandard health product marketed as “GLP-1 (Six-in-One)”, which I purchased via a Facebook adverti*****t. Dear Commissioner, I hereby submit a formal complaint under the Consumer Protection Act (CPA) regarding misleading online advertising and the supply of defective and possibly unsafe goods by a seller advertising the product “GLP-1 (Six-in-One)” on Facebook. 1. Summary of Complaint The seller’s adverti*****t: Presented itself as a South African-based distributor, Promoted what appeared to be a legitimate health/weight-loss product, and Used identical imagery to numerous other Facebook ads now warning about **** products. Based on the above, I reasonably believed I was purchasing a genuine, locally distributed product. 2. Transaction Details Product: GLP-1 (Six-in-One) Quantity: 10 boxes Price Paid: R1,130 3. Grounds for Complaint The transaction violated several provisions of the CPA, including: a) Misrepresentation of supplier location The adverti*****t imp**** the supplier was South African, but the parcel was shipped from China. b) Goods not fit for purpose / ineffective I used the product daily for one month with no effect whatsoever, indicating the goods are defective. c) Potential safety risk The product may be falsified or unregulated, which exposes consumers to potential harm. d) Failure to disclose material information No legitimate manufacturer, distributor address, or South African registration details were provided. Remedies Requested I request that the NCC: Investigate the seller and the misleading Facebook adverti*****ts. Require the seller to issue a full refund of R1,130. Take enforcement action if the conduct breaches the CPA. Liaise with SAHPRA if the product constitutes a health risk. I am willing to provide further information as needed. PUBLIC WARNING: Warning to anyone seeing the GLP-1 (Six-in-One) ads on Facebook. I paid R1,130 for 10 boxes after believing it was a South African supplier. The parcel arrived from China, one month later. I used the product daily for a month with zero results. There are now multiple ads claiming to be the “real” supplier, which raises serious doubts about authenticity. My experience suggests this product is not what is being advertised. Please be cautious and verify before buying. I’ve reported this to SAHPRA, the NCC, and Facebook.
Helpful (0)
|Replies (0)JDS
J.Luis Da Silva
1 reviews | Active since Jun 2023
25 Nov 2025, 16:24
Subject: Complaint Under the Consumer Protection Act — Misrepresentation & Defective Goods: GLP-1 (Six-in-One)
I wish to lodge a formal complaint with SAHPRA regarding a suspected falsified or substandard health product marketed as “GLP-1 (Six-in-One)”, which I purchased via a Facebook adverti*****t. Dear Commissioner, I hereby submit a formal complaint under the Consumer Protection Act (CPA) regarding misleading online advertising and the supply of defective and possibly unsafe goods by a seller advertising the product “GLP-1 (Six-in-One)” on Facebook. 1. Summary of Complaint The seller’s adverti*****t: Presented itself as a South African-based distributor, Promoted what appeared to be a legitimate health/weight-loss product, and Used identical imagery to numerous other Facebook ads now warning about **** products. Based on the above, I reasonably believed I was purchasing a genuine, locally distributed product. 2. Transaction Details Product: GLP-1 (Six-in-One) Quantity: 10 boxes Price Paid: R1,130 3. Grounds for Complaint The transaction violated several provisions of the CPA, including: a) Misrepresentation of supplier location The adverti*****t imp**** the supplier was South African, but the parcel was shipped from China. b) Goods not fit for purpose / ineffective I used the product daily for one month with no effect whatsoever, indicating the goods are defective. c) Potential safety risk The product may be falsified or unregulated, which exposes consumers to potential harm. d) Failure to disclose material information No legitimate manufacturer, distributor address, or South African registration details were provided. Remedies Requested I request that the NCC: Investigate the seller and the misleading Facebook adverti*****ts. Require the seller to issue a full refund of R1,130. Take enforcement action if the conduct breaches the CPA. Liaise with SAHPRA if the product constitutes a health risk. I am willing to provide further information as needed. PUBLIC WARNING: Warning to anyone seeing the GLP-1 (Six-in-One) ads on Facebook. I paid R1,130 for 10 boxes after believing it was a South African supplier. The parcel arrived from China, one month later. I used the product daily for a month with zero results. There are now multiple ads claiming to be the “real” supplier, which raises serious doubts about authenticity. My experience suggests this product is not what is being advertised. Please be cautious and verify before buying. I’ve reported this to SAHPRA, the NCC, and Facebook.
0
Replies (0)